Tudor Borza, MD, MS
Assistant Professor of Urology
Medical School
Available to mentor
Tudor Borza, MD, MS
Assistant Professor
Manage Your Profile
Qualifications
-
Master of Science, Health and Health Care ResearchRackham Graduate School, University of Michigan, Ann Arbor, Michigan, United States
2015 - 2016
-
Doctor of MedicineUniversity of Michigan Medical School, Ann Arbor, Michigan, United States
2006 - 2010
-
Bachelor of Science, ChemistryWayne State University, Detroit, Michigan, United States
2002 - 2006
Center Memberships
-
Center MemberOpioid Research Institute
-
Center MemberInstitute for Healthcare Policy and Innovation
Recent Publications
-
Marchetti KA, Asees A, Bokil AP, Medich M, Durica KC, Rieker J, Rak K, Borza T, Alcorn ML, Davies BJ, Low CA, Stensland KD, Jacobs BL. Urologic Oncology Seminars and Original Investigations, 2026 Jul 1; 44 (7): 234 - 242.Journal ArticleSurvivor-identified barriers and facilitators to acute phase recovery following radical cystectomy
DOI:10.1016/j.urolonc.2026.04.293 -
Lane BR, Lewicki P, Noyes SL, Labardee C, Meah S, Daignault-Newton S, Hafron J, Morgan TM, Radhakrishnan A, Dess RT, Montie J, Ghani KR, Ginsburg KB, Borza T. Cancer, 2026 Feb 15; 132 (4):Journal ArticleIncidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomy
DOI:10.1002/cncr.70291 -
Triner D, Ginsburg KB, Moser A, Labardee C, Korman H, Domina J, Cher ML, Peabody J, Semerjian A, Purysko A, George AK, Borza T, Krumm AE. BJU International, 2026 Jan 1;Journal ArticleUrologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy
DOI:10.1111/bju.70308 PMID: 42095733 -
Ginsburg KB, Zamani A, Borza T. Eur Urol, 2025 Sep 24;Journal ArticleRe: Emmeli Palmstedt, Marianne Månsson, Jonas Hugosson, Rebecka Arnsrud Godtman. Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GOTEBORG-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.06.012.
DOI:10.1016/j.eururo.2025.07.029 PMID: 40998627 -
Srivastava A, Kaufman SR, Shay A, Oerline M, Liu X, Chachlani P, Guro P, Hill D, Van Til M, Linsell S, Labardee C, Dall C, Faraj KS, Maganty A, Ghani KR, Borza T, Ginsburg KB, Hollenbeck BK, Shahinian VB. JAMA Netw Open, 2025 Sep 2; 8 (9): e2530624Journal ArticleA Payment Incentive to Improve Confirmatory Testing in Men With Prostate Cancer.
DOI:10.1001/jamanetworkopen.2025.30624 PMID: 40911309 -
Lane BR, Ginsburg KB, Borza T. JAMA Oncol, 2025 Jul 17;Journal ArticleProper Definition of Postprostatectomy Prostate-Specific Antigen Persistence.
DOI:10.1001/jamaoncol.2025.2117 PMID: 40674092 -
Srivastava A, Daignault-Newton S, Meah S, Faraj K, Ginsburg K, Abdollah F, Labardee C, Johnson A, Semerjian A, Goh KM, Hollenbeck B, Shahinian V, Herrel L, Borza T. Urol Pract, 2025 Jul 10; 101097UPJ0000000000000873Journal ArticleDifferences in the Use and Quality of Active Surveillance for Prostate Cancer Among Men Insured by Medicaid.
DOI:10.1097/UPJ.0000000000000873 PMID: PMC12324826
Featured News & Stories
Health Lab
What does Joe Biden’s prostate cancer diagnosis mean for older patients?
Based on former President Joe Biden's recent diagnosis, a Michigan Medicine urologists discusses routine screening procedures and treatment outcomes.
Health Lab
More men with prostate cancer are avoiding unnecessary surgery
Researchers at University of Michigan showed that the proportion of patients undergoing prostatectomy for the lowest risk type of cancer dropped over fivefold between 2010 to 2024.
